These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 8616946
1. Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. Gent M, Hirsh J, Ginsberg JS, Powers PJ, Levine MN, Geerts WH, Jay RM, Leclerc J, Neemeh JA, Turpie AG. Circulation; 1996 Jan 01; 93(1):80-4. PubMed ID: 8616946 [Abstract] [Full Text] [Related]
2. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. de Valk HW, Banga JD, Wester JW, Brouwer CB, van Hessen MW, Meuwissen OJ, Hart HC, Sixma JJ, Nieuwenhuis HK. Ann Intern Med; 1995 Jul 01; 123(1):1-9. PubMed ID: 7539233 [Abstract] [Full Text] [Related]
3. Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' Group. Gallus A, Cade J, Ockelford P, Hepburn S, Maas M, Magnani H, Bucknall T, Stevens J, Porteous F. Thromb Haemost; 1993 Oct 18; 70(4):562-7. PubMed ID: 7509509 [Abstract] [Full Text] [Related]
4. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Turpie AG, Gent M, Côte R, Levine MN, Ginsberg JS, Powers PJ, Leclerc J, Geerts W, Jay R, Neemeh J. Ann Intern Med; 1992 Sep 01; 117(5):353-7. PubMed ID: 1503326 [Abstract] [Full Text] [Related]
5. Orgaran in the prevention of deep vein thrombosis in stroke patients. Turpie AG. Haemostasis; 1992 Sep 01; 22(2):92-8. PubMed ID: 1379969 [Abstract] [Full Text] [Related]
6. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, Jay RM, Neemeh J. Ann Intern Med; 1991 Apr 01; 114(7):545-51. PubMed ID: 1848054 [Abstract] [Full Text] [Related]
7. Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial. Gerhart TN, Yett HS, Robertson LK, Lee MA, Smith M, Salzman EW. J Bone Joint Surg Am; 1991 Apr 01; 73(4):494-502. PubMed ID: 1707413 [Abstract] [Full Text] [Related]
8. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke. Dumas R, Woitinas F, Kutnowski M, Nikolic I, Berberich R, Abedinpour F, Zoeckler S, Gregoire F, Jerkovic M, Egberts JF. Age Ageing; 1994 Nov 01; 23(6):512-6. PubMed ID: 9231947 [Abstract] [Full Text] [Related]
9. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Powers PJ, Gent M, Jay RM, Julian DH, Turpie AG, Levine M, Hirsh J. Arch Intern Med; 1989 Apr 01; 149(4):771-4. PubMed ID: 2650646 [Abstract] [Full Text] [Related]
10. Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery. Levine MN, Gent M, Hirsh J, Weitz J, Turpie AG, Powers P, Neemeh J, Willan A, Skingley P. Arch Intern Med; 1996 Apr 22; 156(8):851-6. PubMed ID: 8774203 [Abstract] [Full Text] [Related]
11. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. Eriksson BI, Bauer KA, Lassen MR, Turpie AG, Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study. N Engl J Med; 2001 Nov 01; 345(18):1298-304. PubMed ID: 11794148 [Abstract] [Full Text] [Related]
12. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet; 2000 Apr 15; 355(9212):1295-302. PubMed ID: 10776741 [Abstract] [Full Text] [Related]
13. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Hoek JA, Nurmohamed MT, Hamelynck KJ, Marti RK, Knipscheer HC, ten Cate H, Büller HR, Magnani HN, ten Cate JW. Thromb Haemost; 1992 Jan 23; 67(1):28-32. PubMed ID: 1615479 [Abstract] [Full Text] [Related]
15. Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group. Di Carlo V, Agnelli G, Prandoni P, Coccheri S, Gensini GF, Gianese F, Mannucci PM. Thromb Haemost; 1999 Jul 23; 82(1):30-4. PubMed ID: 10456450 [Abstract] [Full Text] [Related]
16. [Heparin-induced thrombocytopenia--a serious complication within the scope of heparin therapy. Follow-up of 7 trauma surgery patients]. Kuhn B. Unfallchirurg; 1997 Aug 23; 100(8):646-51. PubMed ID: 9381213 [Abstract] [Full Text] [Related]
18. The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations. Hill GR, Hickton C, Henderson S, Patton WN. Clin Lab Haematol; 1997 Jun 23; 19(2):155-7. PubMed ID: 9218159 [Abstract] [Full Text] [Related]
19. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M, PEGASUS investigators. Br J Surg; 2005 Oct 23; 92(10):1212-20. PubMed ID: 16175516 [Abstract] [Full Text] [Related]